“Using Light to Save Sight” by Farhad Hafezi
The research group of Prof. Hafezi works on a number of clinical and experimental research projects. Their aim is to develop new and innovative translational approaches for corneal diseases like corneal infection and keratoconus, using techniques ranging from cell biology approaches to multicenter clinical phase III trials. CXL mechanically stiffens the cornea by a process called photopolymerization. Specifically, this process involves UV light that delivers energy in combination with riboflavin (Vitamin B2), which is the substance that induces cross-links in the collagen; the experimental approach of this treatment modality began in 1995.
